Biocon Campus - Biocon
India's Biocon Biologics to receive $150m from Goldman Sachs - Nikkei Asia
BIOCON Stock Price and Chart — NSE:BIOCON — TradingView
Biocon - Wikipedia
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
Covid has created an 'ecosystem' of innovation in India, says Biocon chief Kiran Mazumdar-Shaw | Mint
Biocon announces merger of its arm with Serum Institute subsidiary - BusinessToday
Manufacturing Locations - Biocon
Fortune India: Business News, Strategy, Finance and Corporate Insight
Biocon Campus - Biocon
Biocon Campus - Biocon
Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
Biocon logo in transparent PNG format
Biocon - 72 new faces joined us in February. Many... | Facebook
Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion | The Financial Express
Biocon Biologics' antibody drug unit in Bengaluru gets EU GMP certificate | Business Standard News
Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs - Biocon
Joint drugs controller nabbed taking bribe to clear Biocon Biologics's diabetes injection | Mint
Biocon Biologics Limited | ISPE | International Society for Pharmaceutical Engineering
Biocon in pact with Japan's Yoshindo to commercialise two biosimilar assets | Mint
Biocon engages law firm for governance review after CBI arrests
Biocon Biologics enters licensing agreement with Yoshindo of Japan - The Hindu BusinessLine
Biocon Academy - Biocon
Biocon's pre-tax profit rises 9% to Rs 315 crore in Oct-Dec quarter | Business Standard News
Exclusive | Biocon, Mylan Biosimilar Deal in Last Leg; Serum Institute to Buy Additional Stake of $500 Million in Biocon Biologics: Sources
Biocon Biologics appoints Susheel Umesh as Chief Commercial Officer for emerging markets | Deccan Herald
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
